Table 1a Patient characteristics

From: A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopy

 

(n =26)

Characteristics

n

%

Age (years)

 Median

55

 Range

21–83

Sex

 Male

16

61.5

 Female

10

38.5

WHO performance status

 0

4

15.4

 1

22

84.6

Tumour type

 Gastrointestinal stromal

  

Tumour (GIST)

9

34.6

 Head and neck (SCC)

5

19.2

 Melanoma

5

19.2

 Sarcoma

2

7.7

 Fibromatosis

2

7.7

 Gastric (adenocarcinoma)

1

3.8

 Oesophageal (adenocarcinoma)

1

3.8

 Biliary tract (adenocarcinoma)

1

3.8

  1. Abbreviations: GIST=gastrointestinal stromal tumour; SCC=squamous cell carcinoma.